![]() NanoString NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. | ![]() EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate. | ![]() Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. | ![]() 10X Genomics 10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. | ||||
Founding Date | Founding Date 2003 | Founding Date 2011 | Founding Date 1990 | Founding Date 2007 | Founding Date 2009 | Founding Date 2012 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||||
Locations | Locations Seattle, US HQ Amsterdam, NL | Locations Fremont, US HQ West Wickham, GB | Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US | Locations Laval, CA HQ Ballerup, DK Assago, IT Chevy Chase, US | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Pleasanton, US HQ Shanghai, CN Leiden, NL Singapore, SG San Francisco, US | Locations Salt Lake City, US HQ Wuxi, CN Walluf, DE Willich, DE Milano, IT Doetinchem, NL Calamba, PH see more |
Employees | Employees 7038% decrease | Employees 22344% decrease | Employees 303 | Employees 17 | Employees 2701% decrease | Employees 1,17810% decrease | Employees 2,4004% increase |
Valuation ($) | Valuation ($) 5.1 m | Valuation ($) 340.9 m | Valuation ($) 157.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) 543.9 m |
Financial | |||||||
Revenue (est.) | Revenue (est.) $127.3m (FY, 2022) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) £51.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £122m (FY, 2018) | Revenue (est.) $642.8m (FY, 2025) | Revenue (est.) $844.6m (FY, 2025) |
Cost of goods | Cost of goods $65.5m (FY, 2022) | Cost of goods $53.9m (FY, 2025) | Cost of goods £19.7m (FY, 2025) | Cost of goods N/A | Cost of goods £88.9m (FY, 2018) | Cost of goods $198.9m (FY, 2025) | Cost of goods $554.1m (FY, 2025) |
Gross profit | Gross profit $61.8m (FY, 2022) | Gross profit $15.8m (FY, 2025) | Gross profit £32.1m (FY, 2025) | Gross profit N/A | Gross profit £33.1m (FY, 2018) | Gross profit $443.9m (FY, 2025) | Gross profit $290.5m (FY, 2025) |
Net income | Net income ($159.5m) (FY, 2022) | Net income ($81.3m) (FY, 2025) | Net income £2.5m (FY, 2025) | Net income N/A | Net income £2.5m (FY, 2018) | Net income ($43.5m) (FY, 2025) | Net income ($69.9m) (FY, 2025) |
Operating ⚠ | |||||||
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications 480 (FY, 2019) | Patent Applications 125 (FY, 2020) |
Patents (US) | Patents (US) 34 (Q2, 2022) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 275 (FY, 2020) |
Patents Issued | Patents Issued N/A | Patents Issued 16 (FY, 2021) | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued 200 (FY, 2019) | Patents Issued N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 152m | Total funding raised $ 75m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 195.5m | Total funding raised N/A |

Personalis is a biotechnology company that specializes in cancer genomics.
View company
EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
View company
Klox Technologies is a regenerative medicine company.
View company
Viapath provides pathology and testing its partners, and NHS and private sector organizations.
View company